Type III D mucopolysaccharidosis (Sanfilippo D): Clinical course and symptoms

被引:0
|
作者
Tylki-Szymanska, A
Czartoryska, B
Gorska, D
Piesiewicz-Grzonkowska, E
机构
[1] Childrens Mem Hlth Inst, Dept Metab Dis, PL-04736 Warsaw, Poland
[2] Inst Psychiat & Neurol, Dept Genet, Warsaw, Poland
[3] SZNOZ, Dept Child Neuropsychiat, Warsaw, Poland
来源
ACTA PAEDIATRICA JAPONICA | 1998年 / 40卷 / 05期
关键词
N-acetylglucosamine-6-sulfatase; mucopolysaccharidosis type III D; Sanfilippo D;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A case of a rare form of Sanfilippo disease, mucopolysaccharidosis type III D is presented. The cause of the disease is a deficit of N-acetylglycosamine-6-sulfate sulfatase. Differences in clinical course and symptoms with type A and B Sanfilippo disease are shown (later presentation of symptoms, milder course, lack of distinct psychomotor regression and differences in characteristic phenotypic traits, such as facial features, joint contracture, tall height). It is suggested that type III D mucopolysaccharidosis be taken into account in the differentiation of mental retardation syndromes with hyperactivity.
引用
收藏
页码:492 / 494
页数:3
相关论文
共 50 条
  • [1] TYPE III MUCOPOLYSACCHARIDOSIS (SANFILIPPO DISEASE)
    BURDEA, M
    BRATIANU, A
    RUSU, I
    MAROTEAU.P
    SEMAINE DES HOPITAUX, 1972, 48 (11): : 248 - &
  • [2] CLINICAL HETEROGENEITY IN SANFILIPPO DISEASE (MUCOPOLYSACCHARIDOSIS-III) TYPE-D - PRESENTATION OF 2 NEW CASES
    COPPA, GV
    GIORGI, PL
    FELICI, L
    GABRIELLI, O
    DONTI, E
    BERNASCONI, S
    KRESSE, H
    PASCHKE, E
    MASTROPAOLO, C
    EUROPEAN JOURNAL OF PEDIATRICS, 1983, 140 (02) : 130 - 133
  • [3] SANFILIPPO TYPE-D DISEASE - CLINICAL FINDINGS IN 2 PATIENTS WITH A NEW VARIANT OF MUCOPOLYSACCHARIDOSIS-III
    GATTI, R
    BORRONE, C
    DEVIRGILIS, S
    SANNA, G
    CAO, A
    VONFIGURA, K
    KRESSE, H
    PASCHKE, E
    DURAND, P
    EUROPEAN JOURNAL OF PEDIATRICS, 1982, 138 (02) : 168 - 171
  • [4] Treatment of mucopolysaccharidosis type III (Sanfilippo syndrome)
    Meijer, Olga L. M.
    van Vlies, Naomi
    Wijburg, Frits A.
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (09): : 717 - 730
  • [5] SANFILIPPO (MUCOPOLYSACCHARIDOSIS-III) TYPE-D WITH MILD MENTAL-RETARDATION - A NEW VARIANT
    COPPA, GV
    GIORGI, PL
    FELICI, L
    GABRIELLI, O
    FREDDARA, R
    LEONE, L
    BERNASCONI, S
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1983, 9 (04): : 405 - 408
  • [6] Update of treatment for mucopolysaccharidosis type III (sanfilippo syndrome)
    Kong, Weijing
    Yao, Yanqing
    Zhang, Jing
    Lu, Cheng
    Ding, Yingxue
    Meng, Yan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 888
  • [7] Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome)
    Barone, R
    Nigro, F
    Triulzi, F
    Musumeci, S
    Fiumara, A
    Pavone, L
    NEUROPEDIATRICS, 1999, 30 (05) : 270 - 274
  • [8] Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease)
    de Ruijter, J.
    Broere, L.
    Mulder, M. F.
    van der Ploeg, A. T.
    Rubio-Gozalbo, M. E.
    Wortmann, S. B.
    Visser, G.
    Wijburg, F. A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (03) : 447 - 454
  • [9] Musculoskeletal Manifestations of Sanfilippo Syndrome (Mucopolysaccharidosis Type III)
    White, Klane K.
    Karol, Lori A.
    White, Dustin R.
    Hale, Susan
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2011, 31 (05) : 594 - 598
  • [10] A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome)
    Bhaumik, M
    Muller, VJ
    Rozaklis, T
    Johnson, L
    Dobrenis, K
    Bhattacharyya, R
    Wurzelmann, S
    Finamore, P
    Hopwood, JJ
    Walkley, SU
    Stanley, P
    GLYCOBIOLOGY, 1999, 9 (12) : 1389 - 1396